Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Tracers in Pulmonary Sarcoidosis
NCT02824419Phase 3Terminated
- Sponsor
- Turku University Hospital
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 68Ga-DOTANOC in pulmonary sarcoidosis, sponsored by Turku University Hospital. Started May 2016; status: terminated.
02
Drugs
68Ga-DOTANOC
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT02824419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824419.